Search | Clinical Trials Finder

Conditions: Other Reconstructive Surgery, Failure of Muscle Graft, Cancer, Complications, Surgical Procedure, Unspecified
Interventions: da Vinci® Robotic Surgical System, LD muscle flap harvest procedure, Reconstructive surgery, Questionnaires; Device · Procedure · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Colorectal Lesion, Colorectal Adenoma, Colorectal Polyp, Rectal Lesion, Rectal Adenoma, Rectal Polyp, Sigmoid; Lesion, Sigmoid Colon Polyp
Interventions: Endoscopic submucosal dissection using the ELS System; Device
Lead sponsor: EndoQuest Robotics, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 6
States / cities: Scottsdale, Arizona • Orlando, Florida • Boston, Massachusetts + 2 more

Conditions: Perioperative Chest Pain
Interventions: Lidoderm 5 % Topical Patch, Placebo patch; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Oropharyngeal Cancer
Interventions: Transoral Robotic Surgery (TORS), Modified Barium Swallow (MBS), Questionnaires; Procedure · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hysterectomy, Benign Uterine Diseases
Interventions: benign hysterectomy; Device
Lead sponsor: Distalmotion SA; Industry
Eligibility: 22 Years and older · Female only
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Wichita, Kansas • Houston, Texas

Conditions: Laparoscopic Surgery
Interventions: Carbon dioxide, Bupivacaine, Oxycodone; Other · Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 294 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Kidney Neoplasms
Interventions: Cryoablation Assisted Partial Nephrectomy; Device
Lead sponsor: Urological Research Network, LLC; Other
Eligibility: 55 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2041
U.S. locations: 1
States / cities: Miami Lakes, Florida

Conditions: Endometriosis
Interventions: Participants will receive ICG Dye; Other
Lead sponsor: AdventHealth; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Celebration, Florida

Conditions: Lymphocele After Surgical Procedure
Interventions: lymph node dissection using the peritoneal iliac flap approach to seal lymphatic vessels, Standard surgical approach; Procedure
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years to 80 Years · Male only
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Surgery
Interventions: Robotic Surgery; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Pelvic Organ Prolapse
Interventions: Performing robotic supracervical hysterectomy; Procedure
Lead sponsor: Atlantic Health System; Other
Eligibility: Not listed
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Dysphagia, Pain, Stage I Oropharyngeal Squamous Cell Carcinoma, Stage II Oropharyngeal Squamous Cell Carcinoma, Stage III Oropharyngeal Squamous Cell Carcinoma
Interventions: Dexamethasone, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Transoral Robotic Surgery; Drug · Other · Procedure
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Perioperative/Postoperative Complications, Prostate Cancer
Interventions: robot-assisted laparoscopic surgery, questionnaire administration, intraoperative complication management/prevention; Procedure · Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 191 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Duarte, California

Conditions: Oropharyngeal Squamous Cell Carcinoma, HPV-mediated Oropharyngeal Squamous Cell Carcinoma
Interventions: Radiation Therapy; Radiation
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Stage 0 Hypopharyngeal Cancer, Stage 0 Laryngeal Cancer, Stage 0 Lip and Oral Cavity Cancer, Stage I Adenoid Cystic Carcinoma of the Oral Cavity, Stage I Mucoepidermoid Carcinoma of the Oral Cavity, Stage I Squamous Cell Carcinoma of the Hypopharynx, Stage I Squamous Cell Carcinoma of the Larynx, Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage I Verrucous Carcinoma of the Larynx, Stage I Verrucous Carcinoma of the Oral Cavity, Stage II Adenoid Cystic Carcinoma of the Oral Cavity, Stage II Mucoepidermoid Carcinoma of the Oral Cavity, Stage II Squamous Cell Carcinoma of the Hypopharynx, Stage II Squamous Cell Carcinoma of the Larynx, Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage II Verrucous Carcinoma of the Larynx, Stage II Verrucous Carcinoma of the Oral Cavity, Stage III Adenoid Cystic Carcinoma of the Oral Cavity, Stage III Mucoepidermoid Carcinoma of the Oral Cavity, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Larynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity, Stage IVA Mucoepidermoid Carcinoma of the Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity, Stage IVB Mucoepidermoid Carcinoma of the Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity, Stage IVC Mucoepidermoid Carcinoma of the Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, Tongue Cancer
Interventions: transoral robotic surgery, quality of life assessment; Procedure
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Scoliosis
Interventions: Not listed
Lead sponsor: Mazor Robotics; Industry
Eligibility: 10 Years to 21 Years
Enrollment: 272 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 4
States / cities: San Diego, California • Orlando, Florida • Atlanta, Georgia + 1 more

Conditions: Breast Cancer Female, Breast Cancer, Breast Cancer, Early-Onset, Breast Disease, Breast
Interventions: Robotic NSM, Open NSM; Device · Procedure
Lead sponsor: Intuitive Surgical; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2031
U.S. locations: 15
States / cities: Irvine, California • Los Angeles, California • Jacksonville, Florida + 12 more

Conditions: Opioid Consumption, Postoperative, Multimodal Analgesia, Robotic Assisted Laparoscopic Surgery, Robotic Assisted Laparoscopic Radical Prostatectomy, Prostate Cancer
Interventions: multimodal analgesia pathway with up-front small opioid prescription, multimodal analgesia pathway without up-front small opioid prescription, pre-implementation baseline including opioid; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 45 Years and older · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Incontinence
Interventions: UroCool (Local cooling/hypothermia); Device
Lead sponsor: ZOLL Circulation, Inc., USA; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Duarte, California • Seattle, Washington

Conditions: Oropharyngeal Neoplasms, Head and Neck Cancer
Interventions: Transoral Robotic Surgery (TORS) with the daVinci Robotic Surgical System device; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Post-Operative in-Patients
Interventions: InTouch Telerounding Robot; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 72 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Health Services Research
Interventions: da Vinci Xi System; Device
Lead sponsor: Valley Health System; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Ridgewood, New Jersey

Conditions: Post Operative Pain, Laparoscopic Sleeve Gastrectomy, Robotic Sleeve Gastrectomy, Obesity, Bariatric Surgery Candidate, Quality of Life
Interventions: Laparoscopic Sleeve Gastrectomy (LSG), Robotic Sleeve Gastrectomy (RSG); Procedure
Lead sponsor: Ricard Corcelles; Other
Eligibility: 18 Years to 70 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Oropharyngeal Cancer
Interventions: Toripalimab, Carboplatin, Paclitaxel; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2033
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Robotic Harvest of the Latissimus Dorsi (LD) Muscles

PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System

Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery

Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma

Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Robotic System

Short Title: Standard vs. Lower Pressure Pneumoperitoneum

Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach

Fluorescence Imaging + ICG Dye for Use in the Visual Diagnosis of Endometriosis

Peritoneal Iliac Flap and Lymphocele Formation After Robotic Radical Prostatectomy

Improving Surgeon Performance Measures for Robot-Assisted Surgery

Validation Study for Robotic Surgery Simulator

Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer

Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events After Surgery in Patients With Prostate Cancer

Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.

Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis

Robotic vs. Open NSM for Early Stage Breast Cancer

Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)

Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to Continence

Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck

Use of Robotic Telerounding After Operative Procedures

Comparison of Surgeons' Object Discernment Via Their Hands Versus Using a Robotic Surgical System That Does Not Incorporate Haptics

Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer